Protalix BioTherapeutics (PLX) Interest Expenses (2013 - 2025)
Protalix BioTherapeutics' quarterly Interest Expenses came in at $6000.0 in Q1 2025, down 98.46% year-on-year from $390000.0 in Q1 2024, and down 85.37% quarter-over-quarter from $41000.0 in Q4 2024.
Protalix BioTherapeutics has reported Interest Expenses for 13 years, with the latest figure at $6000.0 in Q1 2025.
- For the quarter ending Q1 2025, Interest Expenses fell 98.46% year-over-year to $6000.0; the trailing twelve-month figure through Dec 2025 stood at $6000.0 (down 99.44% YoY), and the FY2024 full-year result was $1.1 million, down 66.6% from the prior year.
- Interest Expenses for Q1 2025 stood at $6000.0, down from $41000.0 in the prior quarter.
- The five-year high for Interest Expenses was $2.4 million in Q3 2021, with the low at $6000.0 in Q1 2025.
- Average Interest Expenses over 5 years is $851235.3, with a median of $639000.0 recorded in 2022.
- Year-over-year, Interest Expenses soared 109.47% in 2023 and plunged 98.46% in 2025.
- Tracing PLX's Interest Expenses over 5 years: stood at $908000.0 in 2021, then fell by 28.41% to $650000.0 in 2022, then climbed by 19.08% to $774000.0 in 2023, then tumbled by 94.7% to $41000.0 in 2024, then sank by 85.37% to $6000.0 in 2025.
- The last three Interest Expenses figures came in at $6000.0 (Q1 2025), $41000.0 (Q4 2024), and $260000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 260,000.00 |
| Sep 30, 2024 | 260,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | 390,000.00 |
| Mar 31, 2024 | 390,000.00 |
| Dec 31, 2023 | 774,000.00 |
| Dec 31, 2023 | 774,000.00 |
| Sep 30, 2023 | 460,000.00 |
| Sep 30, 2023 | 460,000.00 |
| Jun 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 649,000.00 |
| Mar 31, 2023 | 649,000.00 |
| Dec 31, 2022 | 650,000.00 |
| Dec 31, 2022 | 650,000.00 |
| Sep 30, 2022 | 639,000.00 |
| Sep 30, 2022 | 639,000.00 |
| Jun 30, 2022 | 623,000.00 |
| Jun 30, 2022 | 623,000.00 |
| Mar 31, 2022 | 618,000.00 |
| Mar 31, 2022 | 618,000.00 |
| Dec 31, 2021 | 908,000.00 |
| Dec 31, 2021 | 908,000.00 |
| Sep 30, 2021 | 2.41 Mn |
| Sep 30, 2021 | 2.41 Mn |
| Jun 30, 2021 | 2.20 Mn |
| Jun 30, 2021 | 2.20 Mn |
| Mar 31, 2021 | 2.16 Mn |
| Mar 31, 2021 | 2.16 Mn |
| Dec 31, 2020 | 2.52 Mn |
| Dec 31, 2020 | 2.52 Mn |
| Sep 30, 2020 | 1.97 Mn |
| Sep 30, 2020 | 1.97 Mn |
| Jun 30, 2020 | 1.95 Mn |
| Jun 30, 2020 | 1.95 Mn |
| Mar 31, 2020 | 3.23 Mn |
| Mar 31, 2020 | 3.23 Mn |
| Dec 31, 2019 | 2.09 Mn |
| Dec 31, 2019 | 2.09 Mn |
| Sep 30, 2019 | 2.05 Mn |
| Sep 30, 2019 | 2.05 Mn |
| Jun 30, 2019 | 1.91 Mn |
| Jun 30, 2019 | 1.91 Mn |
| Mar 31, 2019 | 1.92 Mn |
| Mar 31, 2019 | 1.92 Mn |
| Dec 31, 2018 | 1.86 Mn |
| Dec 31, 2018 | 1.86 Mn |
| Sep 30, 2018 | 1.81 Mn |
| Sep 30, 2018 | 1.81 Mn |
| Jun 30, 2018 | 1.79 Mn |
| Jun 30, 2018 | 1.79 Mn |
| Mar 31, 2018 | 2.22 Mn |
| Mar 31, 2018 | 2.22 Mn |
| Dec 31, 2017 | 916,000.00 |
| Dec 31, 2017 | 916,000.00 |
| Sep 30, 2017 | 3.68 Mn |
| Sep 30, 2017 | 3.68 Mn |
| Jun 30, 2017 | 3.05 Mn |
| Jun 30, 2017 | 3.05 Mn |
| Mar 31, 2017 | 2.09 Mn |
| Mar 31, 2017 | 2.09 Mn |
| Dec 31, 2016 | 1.48 Mn |
| Dec 31, 2016 | 1.48 Mn |
| Sep 30, 2016 | 910,000.00 |
| Sep 30, 2016 | 910,000.00 |
| Jun 30, 2016 | 901,000.00 |
| Jun 30, 2016 | 901,000.00 |
| Mar 31, 2016 | 904,000.00 |
| Mar 31, 2016 | 904,000.00 |
| Dec 31, 2015 | 930,000.00 |
| Dec 31, 2015 | 930,000.00 |
| Sep 30, 2015 | 1.03 Mn |
| Sep 30, 2015 | 1.03 Mn |
| Jun 30, 2015 | 642,000.00 |
| Jun 30, 2015 | 642,000.00 |
| Mar 31, 2015 | 1.16 Mn |
| Mar 31, 2015 | 1.16 Mn |
| Mar 31, 2014 | 915,000.00 |
| Mar 31, 2014 | 915,000.00 |
| Mar 31, 2013 | 14,000.00 |
| Mar 31, 2013 | 14,000.00 |